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Cisplatin (CP), an anticarcinogenic agent, is declared to have side effects including cardiotoxicity. Naringin (NA), a 
flavonoid, was shown to have strong antioxidant structure and anti-inflammatory characteristics. Pupose of our study was to 
investigate the protective effects of NA on Caisplatin-induced cardiotoxicity. Sprague-Dawley male rats in the range of 220-
250 g were exerted in this experimental studies. The rats used in experiment separated to 5 groups (10 in each one): Control, 
CP, NA100+CP, NA200+CP and NA200. The groups received drugs for 14 days. The rats were decapitated on 15th day. 
Cardiac tissue and blood samples was taken. When the cardiac tissue was assessed for oxidative stress, a prominent increase 
was found in CP group than other groups (p<0.05). It was assigned that serum CK, CK-MB, LDH, AST and ALT activities 
and levels of cytokines (TNF-alpha, IL-8, IL-1β and IL-6) in the cardiac tissue, a significant increase was found in CP group 
than control group (p<0.05). In both control and NA200+CP groups, similar values obtained for comparative values. 
Caspase 3 and iNOS activity were significantly raised for CP group, compared to NA100+CP and NA200+CP, control 
groups. NA has a protective effect on CP-induced heart injury. It has been determined that NA prevents CP-induced 
apoptosis in the heart. 
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CP which is made of platinum agents, is  
an efficacious member of chemotherapeutic drugs.  
CP is used on oncological cases. It has a wide usage  
in the treatment of various cancer types like ovarian, 
pulmonary, cervical, stomach tissues and cranial1,2. 
And also side effects such as cardiovascular 
complications, hepatotoxicity and nephrotoxicity  
are observed when CP is used3,4. Many studies have 
reported cardiotoxicity due to the CP usage. Congestive 
heart failure, arrhythmia, electrocardiographic changes 
and cardiomyopathy characterize CP. Although CP, an 
anticancer agent, has side effects, it is widely used 
because of its effectiveness. Despite of having side 
effects, CP remains a powerful, commonly used 
anticancer agent5. Nowadays, there is interest in 
medicinal plants having protective effects against 
cardiotoxicity. Food products obtained from these 
medicinal plants are of great interest. Flavonoids are 
polyphenolic compounds and have a variety of 
chemical structures. They are commonly found in 
plant-derived foods like fruits, vegetables, teas and 
wines. Flavonoids are antioxidants that formed 
inherently in biological membranes and prevent lipid 
peroxidation. A flavonoid generally found in grapes 
and other citrus species is NA6. β-glucosidase and  
α-ramnosidase enzymes do the conversion to NA7. 
Antioxidants or cardiomyocytes with antioxidant 
enzymes are used in the pre-treatment stage. At  
this stage, injury of ischemic reperfusion is prevented 
with reduction of the free radicals formation8.  
Several studies have shown that NA exhibits 
antimutagenic, antimicrobial, anti-inflammatory, 
anticancer, antioxidant pharmaceutical effects and free 
radical scavenging9-13. 
In this study, the objective was analyse the 
preventive effects of NA on cardiotoxicity, CP-induced, 
apoptosis and inflamation by commentating the 
biochemical results. When previous studies were 
examined, it was found that this study is the first one 
which investigates the protective effects of NA 
against myocardial damage caused by CP-induced  
in rats. 
—————— 
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Material and methods 
 
Animals 
Animal Experiments Local Ethics Committee 
(HADYEK-No: 230/2018) of Atatürk University 
approved this study. Fifty Sprague Dawley rats which 
are adult and male, weighing approximately 220-250 g, 
were used in this study. The animals were kept at 
appropriate light, room temperature and humidity 
until the day of the experiment and fed with water and 
feed. 
 
Experimental protocol 
Rats were separated into 5 groups as 4 experimental 
groups and 1 control group. 
Group I (Control) The control group received 
solely intragastric (i.g.) saline during 14 days. 
Group II (CP) The group received i.g. saline 
during 14 days (placebo), but however, on the  
12th15 day of the study, this group was given only one 
dose of intraperitoneal (i.p.) CP (15 mg/kg)14 
Group III and IV (NA100+CP and NA200+CP) 
The groups received 100 mg/kg and 200 mg/kg16 of 
NA dissolved in saline, respectively. These groups 
were applied i.g. during 14 days. On the 12th day 
only, this group was given only one dose of 
intraperitoneal (i.p.) CP (15 mg / kg). 
Group V (NA200) The group received a  
200 mg/kg dose of NA along with i.g. during 14 days.  
On the 15th day, all rats were anesthetized. All the 
animals were killed after samples of intracardiac 
blood obtained. The collected cardiac tissue and blood 
samples were used for biochemical examination of 
cytokine levels, oxidative stress, iNOS and Caspase-3 
activity. 
 
Analysis of cardiac function markers 
The blood samples which were collected, were 
centrifuged at 1500 g for 10 min within 1 h to obtain 
sera samples. The sera were stored in the freezer  
at −80°C before analyzing. The CK, CK-MB, LDH, 
AST and ALT in the serum samples were measured.  
 
Analysis of lipid peroxidation and antioxidant 
enzyme activities 
The weight of cardiac tissues was measured. 
Phosphate buffered saline pH 7.4 homogenized this 
measured tissue. The homogenates were centrifuged 
at 10,000 g at 40C during 20 min. 
Then, supernatants were obtained and the 
superoxide dismutase (SOD) activity as well as level 
of nitric oxide (NO), thiobarbituric acid reactive 
substances (TBARS) and the glutathione (GSH) were 
identified as described previously17-20. 
 
Analysis of cytokines levels and iNOS activity  
The rat-specific cytokines levels were identified for 
interleukin-6 (IL-6), tumor necrosis factor-alpha 
(TNF-alpha), interleukin-1β (IL-1β) concentrations 
and interleukin-8 (IL-8). The iNOS activity was 
identified using immunoassay kits (Cayman, USA), 
which were conducted based the protocols of 
manufacturer. The resulted outcomes are expressed as 
the meanSD of the concentration of each factor in 
the tissue.  
 
Analysis of cardiac apoptosis 
The rat-specific caspase-3 activity was identified 
using immunoassay ELISA kits (Elabnscience, USA), 
which were conducted based on the protocols of 
manufacturer. Outcomes were expressed as the 
meanSD of the activity of each factor in the tissue.  
 
Statistical analysis 
All data was analyzed by SPSS 20.00. One-way 
ANOVA was used. Duncan post hoc test was 
evaluated statistically. p<0.05 taken into account 
statistically significant and data was indicated as 
mean±SD. 
 
Results 
 
Naringin effects on the cardiac function tests in 
CP-treated rats 
Some of the experimental group animals’ 15th-day 
cardiac parameters (CK, CK-MB, LDH, AST and ALT) 
are shown in Table 1. The CP-treated rats’ serum CK, 
CK-MB, LDH, AST and ALT activities demonstrated a 
prominent rise when other groups are considered 
(p<0.05), but statistically considerable variety was not 
detected amongst the other groups (p>0.05). 
 
Naringin effects on oxidative stress in CP-treated 
rats 
Activity levels of SOD in cardiac homogenates from 
rats which treated by CP were considerably lower than 
in the control group (p<0.05). Additionally, in the 
group treated with 200 mg NA, the SOD activity levels 
were elevated than in the CP group (p<0.05). Fig. 1 
presents the activities of SOD in the cardiac 
homogenates of rat. 
The GSH levels of the animals which were treated 
by CP were considerably lower than the control group 
(p<0.05). Otherwise, the 100–200 mg NA-treated 
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groups’ levels of GSH were considerably elevated 
than the CP group (p<0.05). Fig. 1 presents statistics 
and levels of GSH for all groups. 
The CP group NO level was considerably higher than 
the control, NA200+CP, and NA200 groups (p<0.05). 
Treatment with the 200 mg dose of NA considerably 
prevented an increase in rats’ NO levels (p<0.05). 
The study also assessed the TBARS levels to 
identify oxidative stress. The CP group’s TBARS 
level was considerably higher than the other groups. 
But, treatment with a 200 mg dose of NA 
significantly prevented an increase in the rats’ 
TBARS level (p<0.05). 
 
Effects of naringin on levels of cardiac cytokines 
(IL-6, TNF-alpha, IL-1β and IL-8) in CP-treated 
rats 
The cytokines revealed that the IL-8, IL-6, and  
IL-1β levels were considerably high in the CP group 
comparison to other groups (p<0.05). In addition, the 
CP and NA100+CP groups’ TNF alpha levels were 
considerably high comparison the other groups (p<0.05). 
NA treatment group had significantly ameliorated 
cytokine levels (p< 005). Fig. 2 presents the levels of 
cytokines in the cardiac homogenates of rat. 
 
Effects of naringin on iNOS activity in CP-treated 
rats 
The iNOS activities were considerably high in the 
CP group comparison to other groups (p<0.05). NA 
administration, especially at high doses, prevented 
increases in the iNOS activity by CP induced. Fig. 3 
presents the activity of iNOS in the cardiac 
homogenates of rat. 
 
Effects of naringin on apoptosis in CP-treated rats 
The caspase 3 activity was considerably high in the 
CP group comparison to other groups (p<0.05). Both 
 
Table 1 Serum cardiac parameters for all groups. The letters indicate the statistical differences among groups (p<0.05, n=10), the results 
were expressed as mean±SD. 
Groups CK ± SD CK-MB ± SD LDH ± SD AST ± SD ALT ± SD 
Control 369 ± 27a 249 ± 34a 488 ± 62a 253 ± 56a 62 ± 11a 
CP 671 ± 5b 536 ± 77b 722 ± 27b 487 ± 22b 94 ± 18b 
NA100+CP 643 ± 80b 329 ± 24a 689 ± 88b 223 ± 25a 58 ± 7a 
NA200+CP 426 ± 49a 216 ± 20a 502 ± 69a 200 ± 15a 64 ± 9a 
NA200 371 ± 63a 247 ± 31a 452 ± 54a 231 ± 33a 69 ± 13a 
Note: The letters were indicate the statistical differences among groups, p value was considered as 0.05 (n=10). 
 
 
 
Fig. 1 — Illustration of levels of oxidative parameters (SOD, GSH, NO and TBARS) for all groups in the cardiac tissues. A; SOD 
activity, B; GSH level, C; NO Level and D; TBARS levels, the letters indicate the statistical differences among groups (p<0.05, n=10), 
the results were expressed as mean+SD 
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doses (100 mg/kg and 200 mg/kg) of NA prevented 
apoptosis caused by CP. Fig. 4 presents the activity of 
caspase 3 in the cardiac homogenates of rat. 
 
Discussion 
CP therapy has been reported to conduce to varied 
arrhythmias like heart failure and ischemic heart 
disease21. The cardiac side effects of CP alone and 
with other chemotherapeutic agents are associated 
with CP-induced oxidative damage22. The objective  
of our study was to analyze protective effects of  
NA CP-induced cardiotoxicity on apoptosis in rats. 
CP which leads to myocardial cells' destruction and 
myocardial endothelial damage, is a cardiotoxic 
agent. Consequently, CK, CK-MB, LDH, AST and 
ALT are given into bloodstream and used as 
diagnostic markers for myocardial tissue damage23. 
High levels of the enzymes listed are related with 
some heart damages like heart failure, myocardial 
infarction and myocarditis. When NA was 
administered, a dose-dependent decrease in high 
biomarkers caused by CP-induced heart damage was 
observed. This kind of effect demonstrates that NA is 
liable for limiting the leakage of biochemical markers 
because of membrane stabilizing properties. 
In the studies, an increased lipid peroxidation, a 
reduced antioxidant capacity in cardiac tissue and a 
significant oxidative stress have reported following 
CP treatment24. CP may cause transient cardiotoxicity, 
contribute to a variety of permanent cardiac 
complications, and even cause congestive heart 
failure25. For these reasons, it is important to note 
drug reactions to CP in the clinic. It is also very 
important to investigate the cardioprotective agent in 
 
 
Fıg. 2 — Biochemical cytokines levels in the cardiac tissues for all groups. A;IL-6, B; TNF-α, C; IL-1β, D; IL-8, the letters indicate the 
statistical differences among groups (p<0.05, n=10), the results were expressed as mean±SD 
 
 
 
Fig. 3 — iNOS activity (ng/g tissue) in the cardiac tissues for all
groups. The letters indicate the statistical differences among
groups (p<0.05, n=10), the results were expressed as mean±SD 
 
 
 
Fig. 4 — Caspase-3 activity in the ardiac tissues for all groups. 
The letters indicate the statistical differences among groups 
(p<0.05, n=10), the results were expressed as mean±SD 
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CP-induced cardiotoxicity. The body has endogenous 
enzymatic antioxidants, like glutathione peroxidase 
(GSH-Px), SOD and catalase (CAT) which supply 
cellular defense against reactive oxygen species 
(ROS)26. In this study, it was observed that levels  
of NO in the heart increased considerably after  
CP administration. Excessive NO production is 
associated with direct cardiac damage in 
cardiotoxicity models linked to other 
chemotherapeutic agents such as CP27. Myocardial 
performance impairment and a negative inotropic 
effect resulting in myocardial injury induction28 were 
referred to the overproduction of NO. In addition, NO 
was reported to cause cellular damage as the end 
result of reducing intracellular GSH levels. NO causes 
oxidative stress-induced cell damage by the 
peroxynitrite anions creation, a cytotoxic intermediate 
which lead to tissue damage and protein 
degradation29. In this study, an increase for NO levels 
and TBARS and a reduction for GSH level and SOD 
activities were observed. NA treatment avoided 
oxidative stress-mediated cellular damage in CP-
induced cardiac damages. 
The proinflammatory cytokines role in the 
cardiotoxicity pathogenesis according to cellular 
signaling pathways is currently under investigation. 
Secretion of cytokine is the inflammation mediator 
and conduces to pathogenesis of tissue injury30,31. 
After CP treatment in rats, a significant connected 
increase have been reported between the 
proinflammatory cytokines and serum IL-6 and  
TNF-α levels32. 
The flavonoids inhibitory effects in the chemical 
mediators release, includingIL-6, IL-1α, and TNF-α 
have been reported33. Rectrictive effects of NA on  
IL-6, IL-1α and TNF-α34 were declared in the 
previous studies. In this study, it was detected that CP 
treatment considerably increased IL-6, IL-1β, IL-8 
and TNF-α levels35-38. Inversely, NA treatment led toa 
prominent reduce in levels of TNF-α, IL-8, IL-1β and 
IL-6 in CP-induced experimental rats. This is 
probably due to its anti-inflammatory features. With 
these findings, it can be concluded that NA cardiac 
inflammation is caused by CP. 
The excessive production of nitric oxide due to 
superoxide anion causes peroxynitrite, which is a 
strong oxidant that causes oxidative damage in the 
cell. Studies show that the cardiomyocytes in mice 
due to the formation of peroxinitrite iNOS resulted in 
heart block and sudden death39. In addition, the nitric 
oxide produced by iNOS induced cardiotoxicity, 
suppressed myocardial contractility and caused 
apoptosis in myocytes40. This study found a 
prominent rise in the nitric oxide level and iNOS 
activities in the cardiac tissue of CP-induced cardio 
toxic rats. But, NA administration had a cardio 
protective effect as it brought the NO and iNOS closer 
to their normal levels. 
A free radical is a production of the body’s 
metabolism that affects cell metabolism and leads to 
apoptosis. ROS which is an important cause of 
secondary heart lesions caused by chemotherapeutic 
drugs, is a product of CP metabolism. ROS 
production can cause cardiomyocyte apoptosis by 
causing lipid peroxidation and cardiomyocyte 
membrane damage41. CP treatment induced 
significant accumulation of ROS and superoxide 
anion in cardiac tissue, suggesting that oxidative 
stress and CP toxicity have close relation which is 
supported by previous studies42. This study shows the 
therapeutic benefit of NA treatment on cardiac 
apoptosis in the CP-induced group. Cardiac caspase-3 
activity, which was increased in CP group, decreased 
after NA treatment. 
 
Conclusion 
NA treatment can mitigate cardiac damage and 
apoptosis caused by CP-induced cardiotoxicity in rats. 
Since NA also has anti-inflammatory, antioxidant and 
anti-apoptotic properties, restoration increases 
oxidative stress. Much more studies are needed to 
research its future clinical applications. 
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